Module 9 2024
First page
Table of contents
Next page
Last page
Cover Page
1
Programme
2
Lecture 1: Overview of Regulation of Biologicals
6
Lecture 2: Preclinical Testing of Biologicals
50
Lecture 3: Clinicals Development of Biopharmaceuticals
66
Lecture 4: Immunogenicity Issues
82
Lecture 5: Quality/CMC Considerations
104
Lecture 6: Module 3 Guideline Requirements
126
Lecture 7: Bioassays
138
Regulation of Biosimilars
168
Lecture 9: Regulation of Vaccines
200
Lecture 10: Regulation of Gene and Cell Therapy Products
248
Made with FlippingBook
Online newsletter creator